Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on France Entertainment Press.
Press releases published on September 16, 2025
Eatwith Advocates for a New Era of Travel: A Return to Authentic Connection Through Food and Hospitality
Eatwith highlights food as the universal language to restore balance, respect, and authenticity in the way we explore the world. PARIS, FRANCE, September 16, 2025 /EINPresswire.com/ -- As the global tourism industry reflects on another record summer …
The Besen Group Celebrates 20 Years of Innovation and Expertise in Mobile Data
WASHINGTON DC , DC, UNITED STATES, September 16, 2025 /EINPresswire.com/ -- The Besen Group, an international mobile data industry management consulting practice headquartered in the Washington DC area, with representatives in Paris and Tokyo, proudly …
SOLUM Empowers European Retailers to Own the Shift from Shelf to Insight at NRF 2025: Retail’s Big Show Europe
LONDON, UNITED KINGDOM, September 16, 2025 /EINPresswire.com/ -- SOLUM will unveil its latest smart retail innovations: Newton Core+, Newton A, and the Newton E-Paper 32” series at NRF 2025 in Paris this week. Integrated into a smart retail platform, …
Airport Sleeping Pods Market Size Worth $196.8 Million by 2034 | CAGR 10.3%
WILMINGTON, NEW CASTLE, DE, UNITED STATES, September 16, 2025 /EINPresswire.com/ -- According to a new report published by Allied Market Research, titled, “Airport Sleeping Pods Market," The Airport Sleeping Pods Market Size was valued at $75 million in …
Données positives de la Phase I randomisée de TG4050, vaccin thérapeutique individualisé néoantigénique contre le cancer – Fin de la randomisation de la partie Phase II au quatrième trimestre 2025
Résultats financiers du 1er semestre 2025 et point sur l’activité Données positives de Phase I évaluant TG4050 dans les cancers opérables de la tête et du cou1 100 % de survie sans récidive après deux ans de suivi des patients – Données communiquées lors d …
Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data Randomization to be Completed in Phase II Part in Q4 2025
2025 Half-Year Results and Business Update Positive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma (HNSCC) 100% disease-free survival after 2 years of follow-up — data presented in a rapid oral presentation at ASCO (June 2025) …
Osivax Announces First Participant Vaccinated in Phase 2b Trial Evaluating Broad-Spectrum Influenza A Vaccine Candidate, OVX836
Phase 2b to assess efficacy, safety, and immunogenicity 2,850 participants to be enrolled across European countries Lyon, France and Liège, Belgium – September 16, 2025 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum …
Atos et Wimi lancent Workplace Souverain, une plateforme de travail collaboratif sécurisée pour le marché français
Communiqué de presse Atos et Wimi lancent Workplace Souverain, une plateforme de travail collaboratif sécurisée pour le marché français Un partenariat stratégique qui vise à sécuriser la collaboration à l’ère de la souveraineté numérique Paris, France – 16 …